Serkan Akdemir

Serkan Akdemir

Auto-generated profile, based on publicly available information

Serkan Akdemir

Department of Urology, Private Tınaztepe Hospital, İzmir, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2023 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
HAHakan Anıl
Hakan Anıl
AGAhmet Guzel
Ahmet Guzel
AYAli Yıldız
Ali Yıldız
SASerkan Akdemir
Serkan Akdemir
KKKaan Karamık
Kaan Karamık
MAMurat Arslan
Murat Arslan
Anıl H, et al. Investig Clin Urol. 2023 May;64:e32. https://doi.org/10.4111/icu.20220361

1 April 2022 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
AYAli Yıldız
Ali Yıldız
HAHakan Anıl
Hakan Anıl
SASerkan Akdemir
Serkan Akdemir
EAEren Erdi Aksaray
Eren Erdi Aksaray
MAMutlu Ateş
Mutlu Ateş
MAMurat Arslan
Murat Arslan
Background: We aim to directly compare the feasibility and safety of extended pelvic lymph node dissection (PLND) during transperitoneal robotic-assisted radical prostatectomy (Tp-RARP) and extraperitoneal laparoscopic radical prostatectomy (Ep-LRP). Materials and Methods: We retrospectively identified the prospectively maintained database records of 162 patients diagnosed with prostate cancer (PC) who underwent Ep-LRP or Tp-RARP with extended PLND. Patients with risk of nodal metastases over 5% according to Briganti nomogram received extended PLND. All data analyzed in this study were based on the documentation in our PC database including age, body mass index, Charlson comorbidity index score, preoperative prostate-specific antigen, history of abdominal surgery, biopsy Gleason score, total operation time, postoperative pelvic drainage time, pathological results, lymph node yield (LNY), percentage lymph node involvement (%LNI), and perioperative complications. Patients were followed up for biochemical recurrence in the postoperative period. Results: Eighty-two of the 162 enrolled patients were in group 1 (Ep-LRP+PLND) and 80 were in group 2 (Tp-RARP+PLND). There were no statistically significant differences between the groups regarding preoperative demographics and clinical characteristics. The median LNY was 17 (range 8–27) and 17.5 (range 10–29) in groups 1 and 2, respectively, and no statistically significant difference was found. There was no significant difference between the groups in terms of biochemical recurrence-free survival with mean follow-up of 44.8 months after radical surgery. Conclusion: Our results support the view that extended PLND through the Ep-LRP approach is a feasible and safe procedure without compromising oncological efficacy compared with a similar template attempted during Tp-RARP. Clinical Trial Registration number is 01/21-2.

1 January 2021 in Urology Research and Practice
Verified
Journal Article
Closed access
AYAli Yıldız
Ali Yıldız
SASerkan Akdemir
Serkan Akdemir
HAHakan Anıl
Hakan Anıl
MAMurat Arslan
Murat Arslan
Objective: This study aimed to assess the perioperative and the 12-month efficacy and safety of 140 W high-powered holmium laser for enucleation of the prostate (HP-HoLEP) for the treatment of benign prostatic obstruction. Material and methods: The data of 540 patients who underwent HoLEP by a single surgeon were analyzed retrospectively. Preoperative evaluation included a physical examination with a digital rectal examination, measurement of maximum urinary flow rate (Qmax), postvoid residual volume (PVR) and prostate volume by transabdominal ultrasonography, serum prostate-specific antigen (PSA), international prostate symptom score (I-PSS) and international index of erectile function-5 (IIEF-5) questionnaires, and urine analysis. Morcellation, enucleation, and operation efficiencies were calculated with the resected weight divided by morcellation, enucleation, and operative times, respectively. The patients were reassessed at 1, 3, 6, and 12 months after surgery by I-PSS, IIEF-5, Qmax, PSA, and the occurrence of complications. Results: The mean operative time was 65.2±20.9 minutes. The mean enucleation time and efficiency were 53±15.1 minutes and 1.72±0.4 g/min, respectively. The mean morcellation time and efficiency were 12.3±15.1 minutes and 7.4±3.2 g/min respectively. Clavien grade 1 complications were observed in 102 (18.9%) patients, Clavien grade 2 complications in 20 (3.7%) patients, and Clavien grade 3b complications in 23 (5.4%) patients. I-PSS, Qmax, and IIEF-5 at postoperative 1, 3, 6, and 12 months were significantly better than baseline results. Conclusion: Our study demonstrated that 140 W HP-HoLEP can be performed with high enucleation efficiency, low perioperative and postoperative complication rates, and excellent functional results. Cite this article as: Yıldız A, Akdemir S, Anıl H, Arslan M. Watt matters: Safety and efficacy of using a 140-W high-powered holmium laser for enucleation of the prostate (HoLEP). Turk J Urol 2021; 47(2): 131-6.


14 March 2022 in Andrologia
Verified
Journal Article
Closed access
ATAltug Tuncel
Altug Tuncel
CACan Aykanat
Can Aykanat
SASerkan Akdemir
Serkan Akdemir
TOTaylan Oksay
Taylan Oksay
MAMurat Arslan
Murat Arslan
OGOzer Guzel
Ozer Guzel
To assess the efficacy and morbidity of the holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia. The study included 60 (55%) and 49 (45%) patients who underwent laser and bipolar enucleation of the prostate respectively. According to the perioperative data, except for length of hospital stay and enucleated prostate weight, all the remaining parameters were similar between the groups. There were significant differences between the preoperative and the postoperative third and 12th month voiding parameters in both groups. In the laser group, the maximum urine flow rate value was better than the bipolar group at the postoperative third and 12th months. However, we did not find any statistically significant difference between the groups in terms of the serum prostate-specific antigen level, International Prostate Symptom Score and postvoid residual urine volume at the postoperative third and 12th months. Our results show that both laser and bipolar techniques are effective minimally invasive surgical treatment options for men with benign prostatic hyperplasia. When compared to bipolar technique, laser technique provides shorter hospital stay, more prostatic tissue enucleation and better maximum urine flow rate values.

30 September 2022 in SDÜ Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
AGAhmet Guzel
Ahmet Guzel
HAHakan Anıl
Hakan Anıl
AYAli Yildiz
Ali Yildiz
KKKaan Karamık
Kaan Karamık
SASerkan Akdemi̇r
Serkan Akdemi̇r
MAMurat Arslan
Murat Arslan
Amaç Üroloji kılavuzlarında 10-20 mm arası alt pol taşlarında özellikle ekstrakorporal şok dalga litotripsi (SWL)'nin başarısız olduğu veya SWL'nin uygun olmadığı durumlarda endoürolojik tedaviler olan perkütan nefrolitotomi (PCNL) ve retrograd intrarenal cerrahi (RİRC) önerilmektedir. Bu çalışmada 10-20 mm arası alt pol taşlarında RİRC ile mini perkütan nefrolitotomi (m-PCNL) uygulanan hastaların sonuçlarını karşılaştırdık. Gereç ve Yöntem 2020 ile 2022 yılları arasında 10-20 mm arası alt pol böbrek taşı nedeniyle endoürolojik tedavi (RİRC veya m-PCNL) uygulanan 116’sı RİRC, 71’i m-PCNL olan toplam 187 hastanın dosyaları retrospektif olarak incelendi. Preoperatif yanlılıkları önlemek için 1:1 oranı temel alınarak eğilim skoru eşleştirmesi (propensity score-match) uygulandı. Analiz sonucuna göre RİRC uygulanan 65 hasta ve m-PCNL uygulanan 65 hasta çalışmaya dahil edildi. İki grup arasında intraoperatif (operasyon süresi, floroskopi süresi) ve postoperatif bulgular (hastane yatış süresi, hematokrit düşüşü, taşsızlık oranları ve komplikasyonlar) karşılaştırıldı. Operasyon sonrası 4 mm veya daha büyük taş saptanması klinik anlamlı rezidü olarak tanımlandı. Komplikasyonlar Clavien skorlama sistemine göre ve intraoperatif-postoperatif olarak sınıflandırıldı. Bulgular Her iki grup, demografik özellikler (yaş, cinsiyet, vücut kitle indeksi), radyografik taş karakteristikleri (taş boyutu, taş lateralitesi, taş opasitesi, ve taş dansitesi) açısından karşılaştırıldığında istatistiksel olarak anlamlı fark gözlenmedi. Operasyon süresi, floroskopi süresi, hastane yatış süresi açısından gruplar karşı- laştırıldığında, RİRC grubunda bu süreler istatistiksel olarak anlamlı derecede daha kısaydı (p